Clinical Trials Logo

Clinical Trial Summary

Stroke is a leading cause of death and disability, and 15 million people suffer a stroke each year; one-third die and one-third are left permanently disabled. Because the risk of stroke increases with age, it has been considered a disease of the elderly, but stroke also occurs in middle-aged people.

Thrombolysis with tissue plasminogen activator (tPA) is the preferred choice of reperfusion therapy of ischemic stroke if performed within 4.5 hours from symptom onset. Time to thrombolysis is associated with improved outcome: the sooner the treatment, the less risk of serious - and possibly permanent - damage to the brain. Unfortunately, only a small fraction of stroke patients make it to thrombolysis within the 4.5-hour; one explanation may be system delays including prolonged transportation.

In May 2010, the first physician-staffed Helicopter Emergency Medical Service (HEMS) was implemented in the Eastern part of Denmark. An observational study evaluating the short-term effects of HEMS implementation compared patients transported by conventional ground ambulance (Ground Emergency Medical Service (GEMS)) to patients transported by HEMS. Patients transported by helicopter had increased time to specialized care. However, both 30-day and 1-year mortality was slightly lower in patients transported by HEMS, although not significant, as was the degree of disability at three months measured by the modified Rankin Scale (mRS).


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02576379
Study type Observational [Patient Registry]
Source Rigshospitalet, Denmark
Contact
Status Completed
Phase N/A
Start date January 2010
Completion date May 2015

See also
  Status Clinical Trial Phase
Completed NCT03104062 - Effect of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients With Acute Myocardial Infarction N/A
Completed NCT04925869 - Prospective Study of Cerebrovascular Accidents (CVA) in 3 French Cities (Besançon, Cayenne and Tours)
Recruiting NCT03901872 - Contemporary Endovascular Therapies in Treatment of Acute Iliofemoral Deep Vein Thrombosis
Completed NCT03785678 - Tenecteplase in Stroke Patients Between 4.5 and 24 Hours Phase 3
Recruiting NCT05424978 - Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an
Not yet recruiting NCT03166059 - CaveoVasc Thrombolysis Protection System, Access Protection Study N/A
Recruiting NCT06149520 - A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis Phase 2
Recruiting NCT02926742 - Submassive Pulmonary Embolism Experience With EKOS N/A
Recruiting NCT06221371 - Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion Phase 3
Active, not recruiting NCT01665885 - Hypothermia in Acute Ischemic Stroke - Surface Versus Endovascular Cooling (HAIS-SE) Phase 2